FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W146148848> ?p ?o ?g. }

• W146148848 endingPage "216" @default.
• W146148848 startingPage "206" @default.
• W146148848 abstract "The aim of this prospective study was to identify the most effective and safest regimen among different thrombolytic treatment strategies. The best treatment strategies for prosthetic valve thrombosis have been controversial. Transesophageal echocardiography–guided thrombolytic treatment was administered to 182 consecutive patients with prosthetic valve thrombosis in 220 different episodes (156 women; mean age, 43.2 ± 13.06 years) between 1993 and 2009 at a single center. These regimens chronologically included rapid (Group I), slow (Group II) streptokinase, high-dose (100 mg) tissue plasminogen activator (t-PA) (Group III), a half-dose (50 mg) and slow infusion (6 h) of t-PA without bolus (Group IV), and a low dose (25 mg) and slow infusion (6 h) of t-PA without bolus (Group V). The endpoints were thrombolytic success, in-hospital mortality, and nonfatal complication rates. The overall success rate in the whole series was 83.2%; it did not differ significantly among Groups I through V (68.8%, 85.4%, 75%, 81.5%, and 85.5%, respectively; p = 0.46). The overall complication rate in the whole series was 18.6%. Although the overall complication rate was similar among Groups I through IV (37.5%, 24.4 %, 33.3%, and 29.6%, respectively; p > 0.05 for each comparison), it was significantly lower in Group V (10.5%, p < 0.05 for each). The combined rates of mortality and nonfatal major complications were also lower in Group V than in the other groups, with all differences significant except for comparison of Groups IV and V. By multivariate analysis, the predictors of combined mortality plus nonfatal major complications were any thrombolytic therapy regimen other than Group V (odds ratios for Groups I through IV: 8.2, 3.8, 8.1, and 4.1, respectively; p < 0.05 for each) and a history of stroke/transient ischemic attack (odds ratio: 3.5, p = 0.011). In addition, there was no mortality in Group V. Low-dose slow infusion of t-PA repeated as needed without a bolus provides effective and safe thrombolysis in patients with prosthetic valve thrombosis. (Comparison of Different TRansesophageal Echocardiography Guided thrOmbolytic Regimens for prosthetIc vAlve Thrombosis; NCT01451320)" @default.
• W146148848 created "2016-06-24" @default.
• W146148848 creator A5003182554 @default.
• W146148848 creator A5003616632 @default.
• W146148848 creator A5006657419 @default.
• W146148848 creator A5007428469 @default.
• W146148848 creator A5021555220 @default.
• W146148848 creator A5027146514 @default.
• W146148848 creator A5036115182 @default.
• W146148848 creator A5036628423 @default.
• W146148848 creator A5052196548 @default.
• W146148848 creator A5057097015 @default.
• W146148848 creator A5060689638 @default.
• W146148848 creator A5062261468 @default.
• W146148848 creator A5067056531 @default.
• W146148848 creator A5068276237 @default.
• W146148848 creator A5080682938 @default.
• W146148848 creator A5081106601 @default.
• W146148848 creator A5084158466 @default.
• W146148848 creator A5090484021 @default.
• W146148848 date "2013-02-01" @default.
• W146148848 modified "2023-10-16" @default.
• W146148848 title "Comparison of Different TEE-Guided Thrombolytic Regimens for Prosthetic Valve Thrombosis" @default.
• W146148848 cites W1463762514 @default.
• W146148848 cites W1595315411 @default.
• W146148848 cites W1964522360 @default.
• W146148848 cites W1972864975 @default.
• W146148848 cites W1976197074 @default.
• W146148848 cites W1977845647 @default.
• W146148848 cites W1995006291 @default.
• W146148848 cites W1997667641 @default.
• W146148848 cites W2017684543 @default.
• W146148848 cites W2018093494 @default.
• W146148848 cites W2021145776 @default.
• W146148848 cites W2027832110 @default.
• W146148848 cites W2043628680 @default.
• W146148848 cites W2069012606 @default.
• W146148848 cites W2069341205 @default.
• W146148848 cites W2087318465 @default.
• W146148848 cites W2097987631 @default.
• W146148848 cites W2109850667 @default.
• W146148848 cites W2155332643 @default.
• W146148848 cites W2163556807 @default.
• W146148848 cites W3106289332 @default.
• W146148848 doi "https://doi.org/10.1016/j.jcmg.2012.10.016" @default.
• W146148848 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23489534" @default.
• W146148848 hasPublicationYear "2013" @default.
• W146148848 type Work @default.
• W146148848 sameAs 146148848 @default.
• W146148848 citedByCount "172" @default.
• W146148848 countsByYear W1461488482013 @default.
• W146148848 countsByYear W1461488482014 @default.
• W146148848 countsByYear W1461488482015 @default.
• W146148848 countsByYear W1461488482016 @default.
• W146148848 countsByYear W1461488482017 @default.
• W146148848 countsByYear W1461488482018 @default.
• W146148848 countsByYear W1461488482019 @default.
• W146148848 countsByYear W1461488482020 @default.
• W146148848 countsByYear W1461488482021 @default.
• W146148848 countsByYear W1461488482022 @default.
• W146148848 countsByYear W1461488482023 @default.
• W146148848 crossrefType "journal-article" @default.
• W146148848 hasAuthorship W146148848A5003182554 @default.
• W146148848 hasAuthorship W146148848A5003616632 @default.
• W146148848 hasAuthorship W146148848A5006657419 @default.
• W146148848 hasAuthorship W146148848A5007428469 @default.
• W146148848 hasAuthorship W146148848A5021555220 @default.
• W146148848 hasAuthorship W146148848A5027146514 @default.
• W146148848 hasAuthorship W146148848A5036115182 @default.
• W146148848 hasAuthorship W146148848A5036628423 @default.
• W146148848 hasAuthorship W146148848A5052196548 @default.
• W146148848 hasAuthorship W146148848A5057097015 @default.
• W146148848 hasAuthorship W146148848A5060689638 @default.
• W146148848 hasAuthorship W146148848A5062261468 @default.
• W146148848 hasAuthorship W146148848A5067056531 @default.
• W146148848 hasAuthorship W146148848A5068276237 @default.
• W146148848 hasAuthorship W146148848A5080682938 @default.
• W146148848 hasAuthorship W146148848A5081106601 @default.
• W146148848 hasAuthorship W146148848A5084158466 @default.
• W146148848 hasAuthorship W146148848A5090484021 @default.
• W146148848 hasConcept C126322002 @default.
• W146148848 hasConcept C141071460 @default.
• W146148848 hasConcept C2776336681 @default.
• W146148848 hasConcept C2780073493 @default.
• W146148848 hasConcept C2780868729 @default.
• W146148848 hasConcept C2781413609 @default.
• W146148848 hasConcept C42219234 @default.
• W146148848 hasConcept C43376680 @default.
• W146148848 hasConcept C500558357 @default.
• W146148848 hasConcept C71924100 @default.
• W146148848 hasConcept C81182388 @default.
• W146148848 hasConceptScore W146148848C126322002 @default.
• W146148848 hasConceptScore W146148848C141071460 @default.
• W146148848 hasConceptScore W146148848C2776336681 @default.
• W146148848 hasConceptScore W146148848C2780073493 @default.
• W146148848 hasConceptScore W146148848C2780868729 @default.
• W146148848 hasConceptScore W146148848C2781413609 @default.
• W146148848 hasConceptScore W146148848C42219234 @default.

• next